Atlas Venture Life Science Advisors, LLC Q2 2025 Filing
Filed August 12, 2025
Portfolio Value
$662.4B
Holdings
11
Report Date
Q2 2025
Filing Type
13F-HR
All Holdings (11 positions)
| Stock | Value |
|---|---|
KYMRKymera Therapeutics, Inc. | $213.7B |
IRONDisc Medicine, Inc. | $126.3B |
DYNDyne Therapeutics, Inc. | $86.9B |
SIONSionna Therapeutics, Inc. | $64.1B |
THRDThird Harmonic Bio, Inc. | $56.5B |
VIGLVigil Neuroscience, Inc. | $46.4B |
DAWNDay One Biopharmaceuticals, Inc. | $41.8B |
KRROKorro Bio, Inc. | $14.2B |
—Ikena Oncology, Inc. | $6.7B |
QTTBQ32 Bio, Inc. | $3.1B |
GBIOGBXGeneration Bio, Co. | $2.7B |